Literature DB >> 32766777

Medical and neurobehavioural phenotypes in male and female carriers of Xp22.31 duplications in the UK Biobank.

Samuel J A Gubb1, Lucija Brcic2, Jack F G Underwood1,3, Kimberley M Kendall1, Xavier Caseras1, George Kirov1, William Davies1,2,3.   

Abstract

Deletions spanning the STS (steroid sulfatase) gene at Xp22.31 are associated with X-linked ichthyosis, corneal opacities, testicular maldescent, cardiac arrhythmia, and higher rates of developmental and mood disorders/traits, possibly related to the smaller volume of some basal ganglia structures. The consequences of duplication of the same genomic region have not been systematically assessed in large or adult samples, although evidence from case reports/series has indicated high rates of developmental phenotypes. We compared multiple measures of physical and mental health, cognition and neuroanatomy in male (n = 414) and female (n = 938) carriers of 0.8-2.5 Mb duplications spanning STS, and non-carrier male (n = 192, 826) and female (n = 227, 235) controls from the UK Biobank (recruited aged 40-69 from the UK general population). Clinical and self-reported diagnoses indicated a higher prevalence of inguinal hernia and mania/bipolar disorder respectively in male duplication carriers, and a higher prevalence of gastro-oesophageal reflux disease and blistering/desquamating skin disorder respectively in female duplication carriers; duplication carriers also exhibited reductions in several depression-related measures, and greater happiness. Cognitive function and academic achievement did not differ between comparison groups. Neuroanatomical analysis suggested greater lateral ventricle and putamen volume in duplication carriers. In conclusion, Xp22.31 duplications appear largely benign, but could slightly increase the likelihood of specific phenotypes (although results were only nominally-significant). In contrast to deletions, duplications might protect against depressive symptoms, possibly via higher STS expression/activity (resulting in elevated endogenous free steroid levels), and through contributing towards an enlarged putamen volume. These results should enable better genetic counselling of individuals with Xp22.31 microduplications.
© The Author(s) 2020. Published by Oxford University Press.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32766777      PMCID: PMC7566349          DOI: 10.1093/hmg/ddaa174

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  43 in total

1.  Neurodevelopmental and associated changes in a patient with Xp22.31 duplication.

Authors:  Christine MacColl; Nina Stein; Mark Tarnopolsky; Jian-Qiang Lu
Journal:  Neurol Sci       Date:  2019-09-05       Impact factor: 3.307

2.  X-linked ichthyosis: Clinical and molecular findings in 35 Italian patients.

Authors:  Andrea Diociaiuti; Adriano Angioni; Elisa Pisaneschi; Viola Alesi; Giovanna Zambruno; Antonio Novelli; May El Hachem
Journal:  Exp Dermatol       Date:  2018-07-02       Impact factor: 3.960

3.  X-Linked Familial Focal Epilepsy Associated With Xp22.31 Deletion.

Authors:  Kenneth A Myers; Elisabeth Simard-Tremblay; Christine Saint-Martin
Journal:  Pediatr Neurol       Date:  2020-04-13       Impact factor: 3.372

4.  First reported case of intrachromosomal cryptic inv dup del Xp in a boy with developmental retardation.

Authors:  Celine Dupont; Aziza Lebbar; Cecile Teinturier; Françoise Baverel; Geraldine Viot; Dominique Le Tessier; Jerome Le Bozec; Laurence Cuisset; Jean-Michel Dupont
Journal:  Am J Med Genet A       Date:  2007-06-01       Impact factor: 2.802

5.  Neurosteroid dehydroepiandrosterone improves active avoidance retrieval and induces antidepressant-like behavior in rats.

Authors:  Janko Samardzic; Boris Hencic; Jasna Jancic; Dragana Jadzic; Milos Djuric; Dragan I Obradovic; Dubravka Svob Strac
Journal:  Neurosci Lett       Date:  2017-09-08       Impact factor: 3.046

6.  Anatomical and functional brain abnormalities in unmedicated major depressive disorder.

Authors:  Xiao Yang; Xiaojuan Ma; Mingli Li; Ye Liu; Jian Zhang; Bin Huang; Liansheng Zhao; Wei Deng; Tao Li; Xiaohong Ma
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-18       Impact factor: 2.570

7.  Identification of new risk factors for rolandic epilepsy: CNV at Xp22.31 and alterations at cholinergic synapses.

Authors:  Laura Addis; William Sproviero; Sanjeev V Thomas; Roberto H Caraballo; Stephen J Newhouse; Kumudini Gomez; Elaine Hughes; Maria Kinali; David McCormick; Siobhan Hannan; Silvia Cossu; Jacqueline Taylor; Cigdem I Akman; Steven M Wolf; David E Mandelbaum; Rajesh Gupta; Rick A van der Spek; Dario Pruna; Deb K Pal
Journal:  J Med Genet       Date:  2018-05-22       Impact factor: 6.318

8.  Indicators of mental disorders in UK Biobank-A comparison of approaches.

Authors:  Katrina A S Davis; Breda Cullen; Mark Adams; Anamaria Brailean; Gerome Breen; Jonathan R I Coleman; Alexandru Dregan; Héléna A Gaspar; Christopher Hübel; William Lee; Andrew M McIntosh; John Nolan; Robert Pearsall; Matthew Hotopf
Journal:  Int J Methods Psychiatr Res       Date:  2019-08-08       Impact factor: 4.035

9.  A prenatal diagnosis and genetics study of five pedigrees in the Chinese population with Xp22.31 microduplication.

Authors:  Jianlong Zhuang; Yuanbai Wang; Shuhong Zeng; Chunling Lv; Yiming Lin; Yuying Jiang
Journal:  Mol Cytogenet       Date:  2019-12-11       Impact factor: 2.009

Review 10.  The Regulation of Steroid Action by Sulfation and Desulfation.

Authors:  Jonathan W Mueller; Lorna C Gilligan; Jan Idkowiak; Wiebke Arlt; Paul A Foster
Journal:  Endocr Rev       Date:  2015-07-27       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.